Direct Oral Anticoagulants (DOAC)
Sponsors
Nakayama Takayuki, Bayer
Conditions
Chronic Disseminated Intravascular Coagulation(Chronic DIC)
DICProphylaxis of Recurrent Venous Thromboembolism in Cancer PatientsTreatment of Venous Thromboembolism in Cancer Patients
Unknown Phase
A pilot study investigating the effects of apixaban in patients with chronic disseminated intravascular coagulation (DIC)
Active, not recruitingJPRN-jRCTs041180072
Start: 2019-03-07Target: 5Updated: 2025-07-18
Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort
CompletedNCT04979780
Start: 2021-07-20End: 2022-03-31Updated: 2024-10-31